SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Madam C. J. Walker — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSarah Walker
Date of birth1867-12-23
IdentifiersMRN HR-ET019-SYN-TD; SSN (made up) 000-19-7062
Document date1917-04-13
AuthorHarriet Okonjo-Bell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Vomiting and diarrhea since the day before yesterday. [S]

History of Present Illness

Madam Walker called this morning and was seen the same day. She came home two days ago from a sales convention where several agents had a stomach illness. That night she began vomiting, four times by morning, with six loose watery stools over the next day and cramping around the navel. The vomiting stopped yesterday afternoon; she is keeping down sips of broth and an oral rehydration drink, and the diarrhea has slowed to two stools today. No blood in the stool and no fever above 37.5 °C. She feels light-headed when she stands quickly. Following the sick-day card in her bag, she has not taken losartan or empagliflozin since the vomiting began; she took nothing for pain. She has kept taking atorvastatin. She is passing less urine than usual. [S]

ElementDetail
OnsetTwo nights ago, after a sales convention
DurationAbout 36 hours
CharacterVomiting, watery diarrhea, crampy pain around the navel
SeverityModerate; vomiting stopped; two stools today
ContextStomach illness among agents at the convention; CKD G3a on losartan 100 mg and empagliflozin
Modifying factorsLosartan and empagliflozin held under her sick-day rules; rehydration drink
Associated signs and symptomsLight-headed on standing; less urine; no blood in the stool, no high fever

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; temperature up to 37.5 °C at home
GastrointestinalPositiveVomiting stopped; watery diarrhea slowing; crampy pain; no blood or black stool
GenitourinaryPositivePassing less urine; no burning
CardiovascularPositiveLight-headed on standing; no chest pain or palpitations
NeurologicalNegativeNo confusion, weakness or severe headache

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg oral tablet, one tablet each morningOne tablet each morning, at the same home time when travelingOral route1917-02-23 to 1917-03-09completedS
Losartan 100 mg oral tablet, one tablet each morningOne tablet each morningOral route1917-03-09activeS
Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgeryOne tablet each morning, with sick-day rulesOral route1917-02-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1917-02-23activeS
Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for nausea, for up to two daysEvery 8 hours as needed for nausea, up to two daysOral route1917-04-13 to 1917-04-15completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1917-04-13Body height163cmS
1917-04-13Body weight76.4kgS
1917-04-13Body mass index (BMI) [Ratio]28.8kg/m2S
1917-04-13Systolic blood pressure112mm[Hg]S
1917-04-13Diastolic blood pressure72mm[Hg]S
1917-04-13Heart rate96/minS
1917-04-13Respiratory rate16/minS
1917-04-13Body temperature37.4CelS
1917-04-13Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1917-04-13Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
1917-04-13Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
1917-04-13Carbon dioxide, total [Moles/volume] in Serum or Plasma21mmol/L22-29 mmol/LLowS
1917-04-13Creatinine [Mass/volume] in Serum or Plasma1.46mg/dL0.59-1.04 mg/dLHighS
1917-04-13Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
1917-04-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M44mL/min/{1.73_m2}60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3aLowS

Physical Exam

Vital signs recorded on 1917-04-13; see the Vital Signs section. [S]

SystemFinding
GeneralTired but alert and talking easily; temperature 37.4 °C
Blood pressure lying and standing112/72 with pulse 96 lying; 102/66 with pulse 108 after two minutes standing, with light-headedness
MouthMucous membranes slightly dry
AbdomenSoft; mild tenderness around the navel without guarding; active bowel sounds; no rebound
SkinSkin turgor slightly reduced; no rash

Problems

ProblemClinical statusVerificationCodeProvenance
Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 1912 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigatedresolvedconfirmed R80.9S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.
Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressureactiveconfirmed I12.9S — Synthetic modern diagnosis anchored to the documented hypertension and nephritis.
Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 1912 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6%activeconfirmed N18.31S — Synthetic kidney findings anchored to the documented nephritis and death from kidney disease.
Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate)activeconfirmed E78.5S — Synthetic laboratory finding.
Viral gastroenteritis after a sales convention, with mild volume depletion and losartan and empagliflozin held under her sick-day rules; no acute kidney injury; resolvedactiveconfirmed A08.4S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)

Follow-up: Nurse phone call tomorrow. Metabolic panel within a week; eleven-week review in two weeks as booked. Emergency care for vomiting that stops her drinking, fainting, no urine for 12 hours, or blood in the stool. Next scheduled visit 1917-04-27: eleven-week review: home readings on maximum losartan, urine albumin, kidney function after a recent gastroenteritis, lipids on atorvastatin. [S]